What are the recommended medications and dosing for treating persistent hiccups?

Recommended Medications for Persistent Hiccups

For persistent hiccups, start with baclofen for central causes (e.g., stroke, CNS lesions) or metoclopramide for peripheral causes (e.g., gastric distension, GERD), as these are the most evidence-based first-line agents. 1

Treatment Algorithm

Step 1: Identify the Likely Cause

• Central causes: Stroke, brain lesions, CNS pathology → Use baclofen
• Peripheral causes: Gastric distension, GERD, diaphragmatic irritation → Use metoclopramide

Step 2: First-Line Pharmacotherapy

Baclofen (for central causes)

• Dosing: Start 5-10 mg three times daily, titrate up to 20 mg three times daily as needed
• Mechanism: GABA-B receptor agonist
• Evidence: Studied in randomized controlled trials 2
• This is your go-to for post-stroke hiccups 1

Metoclopramide (for peripheral causes)

• Dosing: 10 mg three to four times daily (oral or IV)
• Mechanism: Dopamine D2 antagonist, prokinetic
• Evidence: Studied in randomized controlled trials 2
• Caution: Risk of extrapyramidal symptoms and tardive dyskinesia with prolonged use

Step 3: Alternative First-Line Options

Gabapentin

• Dosing: 100 mg three times daily to 400 mg twice daily 3
• Particularly useful in stroke rehabilitation settings where sedation from chlorpromazine would impair participation 3
• Evidence: Multiple case series show effectiveness 3, 2
• Consider this over chlorpromazine in rehabilitation patients to avoid sedation

Chlorpromazine (FDA-approved but problematic)

• Dosing: 25-50 mg three to four times daily
• Major caveat: This is the only FDA-approved medication for hiccups, BUT it causes significant sedation and can impair rehabilitation 3
• Use only when other options fail or sedation is acceptable

Step 4: Second-Line Agents (if first-line fails)

Levosulpiride

• Dosing: 25 mg three times daily 4
• Useful when levomepromazine causes excessive sedation
• Evidence from COVID-19 case reports showing effectiveness 4

Nifedipine (calcium channel blocker)

• Dosing: 30-60 mg daily 5
• Effective in some refractory cases 5, 2

Pregabalin

• Consider when gabapentin fails 6
• Dosing similar to neuropathic pain protocols

Step 5: Refractory Cases

Midazolam

• Reserved for terminal illness or palliative care settings 1
• Provides sedation when quality of life is severely impaired

Haloperidol, Amitriptyline, Valproic Acid

• Limited evidence but reported success in case series 2

Critical Clinical Pitfalls

1. Avoid chlorpromazine in rehabilitation patients - The sedation will sabotage therapy participation despite being FDA-approved 3

2. Don't use metoclopramide long-term - Risk of tardive dyskinesia increases significantly after weeks of use

3. Watch for confusion with gabapentin - One case reported worsened confusion, particularly in elderly stroke patients 3

4. Avoid combining dopamine antagonists - Don't use olanzapine, metoclopramide, phenothiazines, or haloperidol together due to excessive dopamine blockade 7

Evidence Quality Note

The systematic review by 2 found that only baclofen and metoclopramide have been studied in randomized controlled trials, making them the most evidence-based choices. All other agents rely on case series and case reports, though gabapentin has accumulated substantial case series evidence 3, 2. The absence of guidelines specific to hiccups means treatment relies heavily on this research evidence and clinical experience.